Clinical Trials Directory

Trials / Completed

CompletedNCT00949936

Safety and Performance Study of the CAdiscTM-L Lumbar Spinal Disc Replacement Device For CE Marking

Debilitating Low Back paIn: Multi-centre Safety and performanCe invEstigation Of CAdiscTM-L, Total Disc ReplacemeNt Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
Ranier Technology Limited · Industry
Sex
All
Age
25 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this European Union (EU) study to evaluate the safety and performance of the CAdiscTM-L Lumbar Spinal Disc Replacement Device in the surgical replacement of the lumbar intervertebral discs (L3 to S1) for patients requiring surgical intervention for total lumbar disc replacement for the treatment of debilitating, chronic low back pain.

Detailed description

Study Design: International, multicenter, open, clinical investigation with comparison to pre-operative Currently there are two surgical procedures for the treatment of chronic low back pain: Spinal fusion and Total Disc Replacement. CAdisc™-L(Compliant Artificial disc - Lumbar) is a Lumbar total disc replacement product that preserves motion and restores disc height and stability Surgical access is via a routine anterior approach with discectomy (removal of the diseased disc), which is performed prior to implantation of the CAdisc™-L. Instruments are then used to prepare the disc space and to controllably place the replacement disc at the target point. It is not intended for the surgery to differ in type, duration or risk to any other device of this nature.

Conditions

Interventions

TypeNameDescription
DEVICECAdisc™-L (Total Disc Replacement)

Timeline

Start date
2009-10-01
Completion
2010-06-01
First posted
2009-07-31
Last updated
2010-10-15

Locations

4 sites across 4 countries: Belgium, Germany, Netherlands, United Kingdom

Source: ClinicalTrials.gov record NCT00949936. Inclusion in this directory is not an endorsement.